Related Experiment Video
Updated: Dec 20, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
The association between serum levels of growth differentiation factor-15 and rheumatoid arthritis activity
Kamal Esalatmanesh1, Hamidreza Fayyazi1, Roozbeh Esalatmanesh1
1Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Background:
Macrophages play a crucial role in the pathogenesis of rheumatoid arthritis (RA). Growth differentiation factor-15 (GDF-15) acts as an autocrine regulator of macrophage activation.
Objective:
The aim of this study was to assess serum level of GDF-15 as a potential biomarker for detecting RA activity.
Method:
A total of 100 female RA patients and 55 age and weight matched healthy control females were enroled. The serum level of GDF-15 was measured using enzyme-linked immunosorbent assay.
Results:
Serum levels of GDF-15 in RA patients with high, moderate, low and no disease activity were 989.0 ± 161.9, 505.6 ± 220.5, 349.2 ± 155.9 and 349.0 ± 144.0 pg/mL, respectively. GDF-15 with a cut-off value higher than 705 pg/mL was indicative of high RA activity with sensitivity of 96% and specificity of 92%.
Conclusion:
GDF-15 serum levels may be used as a biomarker to predict high RA disease activity.
Insights
Growth Differentiation Factor-15 (GDF-15) shows promise as a biomarker for rheumatoid arthritis (RA) activity. Elevated serum GDF-15 levels accurately predict high RA disease activity, aiding in patient management.
Area of Science:
- Rheumatology
- Immunology
- Biomarker Discovery
Background:
- Macrophages are key players in rheumatoid arthritis (RA) pathogenesis.
- Growth Differentiation Factor-15 (GDF-15) regulates macrophage activation.
Purpose of the Study:
- To evaluate serum GDF-15 as a potential biomarker for RA disease activity.
- To correlate GDF-15 levels with varying degrees of RA activity.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure serum GDF-15.
- Study included 100 female RA patients and 55 healthy female controls.
Main Results:
- Serum GDF-15 levels were significantly higher in RA patients with high disease activity (989.0 ± 161.9 pg/mL).
- A GDF-15 cutoff >705 pg/mL predicted high RA activity with 96% sensitivity and 92% specificity.
Conclusions:
- Serum GDF-15 levels can serve as a valuable biomarker for predicting high rheumatoid arthritis disease activity.
- GDF-15 may assist in clinical assessment and management of RA patients.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease I: Introduction

